Actress Lori Loughlin and her fashion designer husband, Mossimo Giannulli, have agreed to plead guilty to charges in the college admissions bribery case and serve two months in prison, according to court papers filed Thursday.

The couple agreed to plead guilty to conspiracy to commit wire and mail fraud in a plea agreement filed in Boston’s federal court. The charge carries up to 20 years in prison and a fine of $250,000.

Prosecutors have agreed to dismiss charges of money laundering and federal programs bribery that were added after the case was filed.

“Under the plea agreements filed today, these defendants will serve prison terms reflecting their respective roles in a conspiracy to corrupt the college admissions process and which are consistent with prior sentences in this case," said United States Attorney Andrew Lelling. "We will continue to pursue accountability for undermining the integrity of college admissions.”

An attorney for the couple declined to comment.

Loughlin and Giannulli previously pleaded not guilty and firmly insisted on their innocence even as other parents reached deals with prosecutors. The couple are the 23rd and 24th parents to plead guilty in the case.

Loughlin and Giannulli are accused of paying $500,000 in bribes to get their daughters into the University of Southern California as crew team recruits, even though neither of them played the sport.

Share:
More In Culture
Pear Therapeutics CEO on How Its Apps Work for Conditions Like Addiction
Digital medical care provider Pear Therapeutics rang the closing bell on the Nasdaq Friday and President and CEO Dr. Corey McCann, joined Cheddar to talk about how the company plans to grow the business of software-based therapeutics and how the first FDA authorized prescription digital therapeutics company will go about treating illnesses like insomnia and addiction. "These really are pieces of software. In many cases, they're apps and in the cases of our addiction products, these are based on something called cognitive behavioral therapy or CBT," he said. "These products change the patient's brain circuitry to help them be abstinent, to help them stay in treatment, and that's exactly what we see in randomized clinical trials and that's what we see in the real world." He also addressed the ongoing mental health crises brought on by the pandemic. **copy updated to remove IPO information as Pear Therapeutics went public in December**
Bitcoin Price Tumbles First Week of 2022
Ben Armstrong, founder of Bitboy Crypto, joins Cheddar News to discuss Bitcoin's downward trend and what's next for crypto after protests in Kazakhstan cause crypto miners to shut down.
Pearson CEO Says Flexibility Is Key to Maximize Remote Instruction for Students
The highly transmissible omicron variant of COVID-19 has forced school districts nationwide to return to virtual instruction, but there remain concerns about the quality of education students are receiving online. Andy Bird, CEO of Pearson, an education publisher and assessment service provider, joined Cheddar's "Opening Bell" to talk about steps educators and parents can take to make the remote learning experience an easier one, noting that one of the biggest advantages teachers can have is flexibility. "You cannot take a rigid timetable that works in the analog world and replicate that in the digital world. You need to have flexibility. Asynchronous learning, I think, is a very important part," he told Cheddar.
2022 Goals for Business Owners
Julie Elledge, Founder and CEO of Mentor Agility, joins ChedHER to discuss what goals business owners should set in the new year, and what tools are out there for emerging entrepreneurs.
Load More